Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives $56.00 Average Target Price from Brokerages

Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) have received a consensus recommendation of “Buy” from the seventeen brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, twelve have issued a buy rating and four have assigned a strong buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $56.00.

Several equities analysts have recently commented on the company. Wedbush reiterated an “outperform” rating and set a $58.00 target price on shares of Scholar Rock in a research note on Tuesday, July 21st. Canaccord Genuity Group assumed coverage on shares of Scholar Rock in a report on Monday, April 20th. They issued a “buy” rating and a $62.00 price target on the stock. HC Wainwright increased their price objective on shares of Scholar Rock from $58.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Cantor Fitzgerald reissued an “overweight” rating on shares of Scholar Rock in a report on Thursday, June 18th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Scholar Rock in a research report on Friday, July 17th.

Scholar Rock Trading Up 0.9%

Shares of SRRK opened at $49.37 on Friday. The company has a market capitalization of $5.92 billion, a P/E ratio of -13.75 and a beta of 0.67. Scholar Rock has a one year low of $27.07 and a one year high of $58.49. The company has a debt-to-equity ratio of 0.71, a quick ratio of 8.64 and a current ratio of 8.64. The stock has a 50-day moving average price of $50.09 and a 200 day moving average price of $47.60.

Scholar Rock (NASDAQ:SRRK) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.83) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.82) by ($0.01). During the same quarter in the previous year, the business posted ($0.67) earnings per share. Sell-side analysts forecast that Scholar Rock will post -3.23 EPS for the current fiscal year.

Insider Buying and Selling at Scholar Rock

In related news, Director Michael Gilman sold 2,544 shares of Scholar Rock stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $53.87, for a total value of $137,045.28. Following the completion of the transaction, the director directly owned 59,511 shares in the company, valued at approximately $3,205,857.57. This trade represents a 4.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jeffrey S. Flier sold 3,053 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $53.88, for a total value of $164,495.64. Following the sale, the director owned 27,856 shares in the company, valued at $1,500,881.28. The trade was a 9.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 17,149 shares of company stock valued at $923,108. Corporate insiders own 10.30% of the company’s stock.

Hedge Funds Weigh In On Scholar Rock

Large investors have recently added to or reduced their stakes in the company. Jennison Associates LLC increased its position in Scholar Rock by 74.0% in the fourth quarter. Jennison Associates LLC now owns 2,795,188 shares of the company’s stock worth $123,128,000 after buying an additional 1,188,676 shares during the period. iA Global Asset Management Inc. acquired a new position in shares of Scholar Rock during the fourth quarter valued at $5,430,000. Geode Capital Management LLC grew its position in shares of Scholar Rock by 4.1% during the fourth quarter. Geode Capital Management LLC now owns 2,034,024 shares of the company’s stock worth $89,616,000 after acquiring an additional 79,214 shares during the last quarter. Norges Bank acquired a new stake in shares of Scholar Rock in the 4th quarter worth about $91,603,000. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake in shares of Scholar Rock in the 4th quarter worth about $4,546,000. 91.08% of the stock is currently owned by institutional investors.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).